Quadrant Capital Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,724
| Closed | -$120K | – | 2536 |
|
|
2025
Q1 | $120K | Buy |
6,724
+102
| +2% | +$1.83K | ﹤0.01% | 1483 |
|
|
2024
Q4 | $115K | Hold |
6,622
| – | – | 0.01% | 985 |
|
|
2024
Q3 | $92.6K | Hold |
6,622
| – | – | 0.01% | 1111 |
|
|
2024
Q2 | $54.4K | Buy |
6,622
+4,554
| +220% | +$37.4K | ﹤0.01% | 1362 |
|
|
2024
Q1 | $15.9K | Sell |
2,068
-391
| -16% | -$3.02K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $22.1K | Buy |
2,459
+2,419
| +6,048% | +$21.7K | ﹤0.01% | 1772 |
|
|
2023
Q3 | $358 | Buy |
+40
| New | +$358 | ﹤0.01% | 2618 |
|
|
2023
Q2 | – | Sell |
-41
| Closed | -$923 | – | 2777 |
|
|
2023
Q1 | $923 | Buy |
+41
| New | +$923 | ﹤0.01% | 2547 |
|
|
2021
Q4 | – | Sell |
-41
| Closed | -$1K | – | 2699 |
|
|
2021
Q3 | $1K | Buy |
+41
| New | +$1K | ﹤0.01% | 2399 |
|